BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12068144)

  • 1. Expression patterns of cytokeratins in cholesteatomas: evidence of increased migration and proliferation.
    Kim HJ; Tinling SP; Chole RA
    J Korean Med Sci; 2002 Jun; 17(3):381-8. PubMed ID: 12068144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased proliferation and migration of epithelium in advancing experimental cholesteatomas.
    Kim HJ; Tinling SP; Chole RA
    Otol Neurotol; 2002 Nov; 23(6):840-4. PubMed ID: 12438843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression patterns of cytokeratins in retraction pocket cholesteatomas.
    Kim HJ; Tinling SP; Chole RA
    Laryngoscope; 2001 Jun; 111(6):1032-6. PubMed ID: 11404616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratinocyte differentiation in acquired cholesteatoma and perforated tympanic membranes.
    Vennix PP; Kuijpers W; Peters TA; Tonnaer EL; Ramaekers FC
    Arch Otolaryngol Head Neck Surg; 1996 Aug; 122(8):825-32. PubMed ID: 8703383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of cell proliferation using BrdU labelling on tympanic membrane, external auditory canal and induced cholesteatoma in Mongolian gerbils.
    Park K; Chun YM; Park HJ; Lee YD
    Acta Otolaryngol; 1999; 119(8):874-9. PubMed ID: 10728926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues.
    Broekaert D; Coucke P; Leperque S; Ramaekers F; Van Muijen G; Boedts D; Leigh I; Lane B
    Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):931-8. PubMed ID: 1280020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative cytokeratin distribution patterns in cholesteatoma epithelium.
    Olszewska E; Sudhoff H
    Histol Histopathol; 2007 Jan; 22(1):37-42. PubMed ID: 17128409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphologic and biologic changes of experimentally induced cholesteatoma in Mongolian gerbils with anticytokeratin and lectin study.
    Kim CS; Chung JW
    Am J Otol; 1999 Jan; 20(1):13-8. PubMed ID: 9918165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proliferative potential of the ear drum in the process of gerbiline cholesteatoma formation].
    Shimoya S; Makino K; Omura F; Amatsu M
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Aug; 101(8):1029-37. PubMed ID: 9778949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gerbilline cholesteatoma development Part III. Increased proliferation index of basal keratinocytes of the tympanic membrane and external ear canal.
    Tinling SP; Chole RA
    Otolaryngol Head Neck Surg; 2006 Jul; 135(1):116-23. PubMed ID: 16815195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cytokeratins 13 and 16 in middle ear cholesteatoma.
    Sasaki H; Huang CC
    Otolaryngol Head Neck Surg; 1994 Mar; 110(3):310-7. PubMed ID: 7510866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversibility of experimental cholesteatoma epithelium using Mongolian gerbils.
    Park K; Choung YH; Chun YM; Lee JS; Hong SP
    Acta Otolaryngol; 2005 May; 125(5):540-6. PubMed ID: 16092548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of epidermal differentiation in middle ear cholesteatoma.
    Stammberger M; Bujía J; Kastenbauer E
    Am J Otol; 1995 Jul; 16(4):527-31. PubMed ID: 8588655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gerbilline cholesteatoma development. Part II: temporal histopathologic changes in the tympanic membrane and middle ear.
    Tinling SP; Chole RA
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):953-60. PubMed ID: 16730537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.
    Shinoda H; Huang CC
    Laryngoscope; 1995 Nov; 105(11):1232-7. PubMed ID: 7475882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new theory on the pathogenesis of acquired cholesteatoma: Mucosal traction.
    Jackler RK; Santa Maria PL; Varsak YK; Nguyen A; Blevins NH
    Laryngoscope; 2015 Aug; 125 Suppl 4():S1-S14. PubMed ID: 26013635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current concepts of the pathogenesis of acquired middle ear cholesteatoma].
    Welkoborsky HJ
    Laryngorhinootologie; 2011 Jan; 90(1):38-48; quiz 49-50. PubMed ID: 21225533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The research progress of keratin's roles in the pathology of middle ear cholesteatoma].
    Feng YS; Si Y; Zhang ZG
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Nov; 54(11):870-874. PubMed ID: 31795552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratinocyte growth factor receptor (KGF-R) in cholesteatoma tissue.
    Barbara M; Raffa S; Murè C; Manni V; Ronchetti F; Monini S; Torrisi MR
    Acta Otolaryngol; 2008 Apr; 128(4):360-4. PubMed ID: 18368565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.
    Holly A; Sittinger M; Bujia J
    Eur Arch Otorhinolaryngol; 1995; 252(6):366-9. PubMed ID: 8679157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.